Dean Allison

[Questions on the Order Paper, September 15th, 2025]

With regard to information arising from an access to information request from the Public Health Agency of Canada – A-2023-000165, which stated that the Chief Public Health Officer Dr. Theresa Tam and “quite a few” pandemic managers at the Department of Health, the Public Health Agency of Canada, the Department of Industry, the Department of Foreign Affairs, Trade and Development and the Department of National Defence were required to sign a secret oath promising never to divulge information that “may result in embarrassment”: (a) which specific individual or individuals initiated the requirement for staff to sign a confidentiality agreement; (b) which divisions of which departments did the individual or individuals in (a) work in; (c) who was asked to sign this confidentiality agreement and what positions did they hold in their respective departments; (d) which divisions of which departments did the individuals in (c) work in; (e) what were the details of the confidentiality agreement; (f) why did the government feel such a confidentiality agreement was necessary; (g) did the government conceal or attempt to conceal any information from the public and media that could result in embarrassment; (h) if the answer to (g) is affirmative, what was the specific information that the government concealed or attempted to conceal from the public and media that could result in embarrassment; (i) what specific criteria do Department of Health officials use to determine whether it's more important to not embarrass the government versus the requirement to be open and transparent with Canadians; (j) are the staff who signed this confidentiality agreement still under a legal obligation to meet the demands as outlined in the confidentiality agreement; (k) under what other circumstances are these types of confidentiality agreements required of bureaucratic staff; (l) how did this confidentiality agreement differ from the Values and Ethics Code for the Public Sector; (m) who specifically wrote the confidentiality agreement and which division and which department do they work in; and (n) who approved the requirements of the confidentiality agreement?

[Questions on the Order Paper, September 15th, 2025]

With regard to Health Canada’s review of the manufacturing data, quality control and safety of lipid nanoparticles in the mRNA COVID-19 vaccines including all versions of Moderna’s SpikeVax, Pfizer-BioNTech’s Comirnaty and the boosters, and Onpattro (patisaran): (a) was the purity of the starting materials for the lipids, such as residual halogenated solvents and elements, including metals, assessed for mutagenic risk in accordance with established norms and guidelines, and, if so, what were the results, and, if not, why not; (b) was the total amount of observed impurities assessed for mutagenic risk, and, if so, what were the results, and, if not, why not; (c) were any individual element impurities considered mutagenic; (d) if the answer to (c) is affirmative, was this assessed with respect to multiple doses and with respect to the nature of transfection of the lipid nanoparticles; (e) was any assessment of the lipid nanoparticle as a nanoparticle performed; (f) if the answer to (e) is affirmative, did this include an assessment of the polyethylene glycol moiety; (g) was an assessment of the risk of complement activation-related pseudoallergy due to the polyethylene glycol moiety performed, and, if so, what were the results, and, if not, why not; and (h) were any complement-related assays requested from the manufacturer, and, if not, why not?

[Questions on the Order Paper, September 15th, 2025]

With regard to the Public Health Agency of Canada and the government’s future health approach: (a) which agency, entities or ministries are involved in (i) the pandemic prevention, preparedness and response protocols, (ii) the One Health approach; (b) what is the One Health approach and where or how did it originate; (c) which bills are currently tabled or have been passed which would operationalize (i) Canada’s pandemic prevention, preparedness and response protocols, (ii) the One Health approach in Canada, (iii) any other World Health Organization or United Nations international health or pandemic treaties or agreements; (d) have staff already been hired or will staff be hired and trained to integrate the One Health approach into Canadian policy and legislation; (e) if the answer to (d) is affirmative, (i) where and under which department or agency will these employees work, (ii) where are these positions posted, (iii) what are the hiring criteria for these staff, (iv) who selects the staff, (v) how many positions exist or will be created; (f) what is the budget allocation to integrate the One Health approach; (g) are there training programs for nongovernmental professionals in One Health and, if so, where are they located; and (h) if the answer to (g) is affirmative, (i) how are the training programs funded, (ii) what are their goals, (iii) who instructs these courses, (iv) what are the requirements to instruct these courses, (v) how did the instructors obtain these requirements?

[Business of Supply, June 10th, 2025]

Mr. Speaker, will the government continue to increase countertariffs on U.S. products coming into Canada? This is a very important question that comes up all the time when I am speaking to businesses and farmers in my riding.

[Business of Supply, June 10th, 2025]

Mr. Speaker, in terms of countertariffs on the U.S., what is the government's solution and approach to the doubling of the U.S. tariffs on Canadian steel and aluminum? I ask him to be specific so my constituents are informed.

[Business of Supply, June 10th, 2025]

Mr. Speaker, what are the precise criteria that the government uses to place an import tariff on agriculture products?

[Business of Supply, June 10th, 2025]

Mr. Speaker, for the products being imported to Canada by a farmer or a business and not available anywhere else except in a country with which Canada has a difficult relationship, is there a process by which the farmer or business owner can retrieve the import tariff imposed by Canada?

[Business of Supply, June 10th, 2025]

Mr. Speaker, I have a question on fertilizer and tariffs, specifically cases when fertilizer is available only from nations with which Canada does not have a great relationship. How does the Government of Canada determine the percentage of tariffs imposed on such countries as it relates specifically to fertilizer?

[Business of Supply, June 10th, 2025]

Mr. Speaker, are there any publicly available guidelines or processes farmers and businesses in my riding can look at to get a better understanding of how the Government of Canada makes decisions on countertariffs or tariffs in general?

[Business of Supply, June 10th, 2025]

Mr. Speaker, I want to talk about tariffs. How does the government come up with criteria for countertariffs on agriculture products? Is there a framework that is followed, or is it on a case-by-case basis?